...
首页> 外文期刊>Journal of experimental & clinical cancer research : >miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer
【24h】

miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer

机译:miR-27b-3p通过靶向像孤儿受体1的酪氨酸激酶受体抑制胃癌的细胞增殖

获取原文

摘要

The receptor tyrosine kinase-like orphan receptors (ROR) family contains the atypical member ROR1, which plays an oncogenic role in several malignant tumors. However, the clinical potentials and underlying mechanisms of ROR1 in gastric cancer progression remain largely unknown. In this study, we validated the microRNA-mediated gene repression mechanism involved in the role of ROR1. Bioinformatic prediction, luciferase reporter assay, quantitative real-time PCR (qRT-PCR) and western blotting were used to reveal the regulatory relationship between miR-27b-3p and ROR1. The expression patterns of miR-27b-3p and ROR1 in human gastric cancer (GC) specimens and cell lines were determined by microRNA RT-PCR and western blotting. Cell proliferation, colony formation assay in soft agar in vitro and tumorigenicity in vivo were performed to observe the effects of downregulation and upregulation miR-27b-3p expression on GC cell phenotypes. miR-27b-3p suppressed ROR1 expression by binding to the 3’UTR of ROR1 mRNA in GC cells. miR-27b-3p was significantly downregulated and reversely correlated with ROR1 protein levels in clinical samples. Analysis of the clinicopathological significance showed that miR-27b-3p and ROR1 were closely correlated with GC characteristics. Ectopic miR-27b-3p expression suppressed cell proliferation, colony formation in soft agar, xenograft tumors of GC cells. By contrast, miR-27b-3p knockdown enhanced these malignant behaviors. Our studies further revealed that the c-Src/STAT3 signaling pathway was involved in miR-27b-3p-ROR1-mediated cell proliferation regulation. These results show that miR-27b-3p suppresses ROR1 expression through the binding site in the 3’UTR inhibiting the cell proliferation. These findings indicate that miR-27b-3p exerts tumor-suppressive effects in GC through the suppression of oncogene ROR1 expression and suggest a therapeutic application of miR-27b-3p in GC.
机译:受体酪氨酸激酶样孤儿受体(ROR)家族包含非典型成员ROR1,该成员在几种恶性肿瘤中起致癌作用。然而,ROR1在胃癌进展中的临床潜力和潜在机制仍然未知。在这项研究中,我们验证了参与ROR1作用的microRNA介导的基因阻抑机制。利用生物信息学预测,荧光素酶报告基因分析,实时荧光定量PCR(qRT-PCR)和western blotting揭示了miR-27b-3p与ROR1之间的调控关系。通过microRNA RT-PCR和western blotting检测miR-27b-3p和ROR1在人胃癌(GC)标本和细胞系中的表达模式。进行细胞增殖,体外软琼脂中的集落形成测定和体内致瘤性,以观察miR-27b-3p表达下调和上调对GC细胞表型的影响。 miR-27b-3p通过与GC细胞中ROR1 mRNA的3'UTR结合来抑制ROR1表达。 miR-27b-3p显着下调,并与临床样品中的ROR1蛋白水平反向相关。临床病理意义分析表明,miR-27b-3p和ROR1与GC特征密切相关。异位miR-27b-3p的表达抑制了细胞增殖,软琼脂中的集落形成,GC细胞的异种移植肿瘤。相比之下,miR-27b-3p敲低可增强这些恶性行为。我们的研究进一步揭示了c-Src / STAT3信号通路参与了miR-27b-3p-ROR1介导的细胞增殖调控。这些结果表明,miR-27b-3p通过3'UTR中的结合位点抑制ROR1表达,从而抑制细胞增殖。这些发现表明,miR-27b-3p通过抑制癌基因ROR1的表达在GC中发挥肿瘤抑制作用,并暗示了miR-27b-3p在GC中的治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号